Authors: Adamson, PC Widemann, BC Reaman, GH Seibel, NL Murphy, RF Gillespie, AF Balis, FM

Citation: Pc. Adamson et al., A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: A Joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group Study, CLIN CANC R, 7(10), 2001, pp. 3034-3039

Authors: Seibel, NL Blaney, SM O'Brien, M Krailo, M Hutchinson, R Mosher, RB Balis, FM Gregory, H

Citation: Nl. Seibel et al., Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: A collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial, CLIN CANC R, 5(4), 1999, pp. 733-737

Authors: Frangoul, H Ames, MM Mosher, RB Reid, JM Krailo, MD Seibel, NL Shaw, DWW Steinherz, PG Whitlock, JA Holcenberg, JS

Citation: H. Frangoul et al., Phase I study of topotecan administered as a 21-day continuous infusion inchildren with recurrent solid tumors: A report from the Children's Cancer Group, CLIN CANC R, 5(12), 1999, pp. 3956-3962

Authors: Walsh, TJ Seibel, NL Arndt, C Harris, RE Dinubile, MJ Reboli, A Hiemenz, J Chanock, SJ

Citation: Tj. Walsh et al., Amphotericin B lipid complex in pediatric patients with invasive fungal infections, PEDIAT INF, 18(8), 1999, pp. 702-708

Authors: Arkin, S Cooper, HA Hutter, JJ Miller, S Schmidt, ML Seibel, NL Shapiro, A Warrier, I

Citation: S. Arkin et al., Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors - Results of the NovoSeven emergency-use program, HAEMOSTASIS, 28(2), 1998, pp. 93-98